We are live on ! Find out more
DSGN icon

Design Therapeutics
DSGN

88 hedge funds and large institutions have $85.5M invested in Design Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

10% more capital invested

Capital invested by funds: $77.6M → $85.5M (+$7.92M)

1% more funds holding

Funds holding: 87 → 88 (+1)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.1% less ownership

Funds ownership: 58.7% → 57.61% (-1.1%)

24% less call options, than puts

Call options by funds: $253K | Put options by funds: $335K

Holders
88
Holders Change
+1
Holders Change %
+1.15%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
36
Reduced
25
Closed
14
Calls
$253K
Puts
$335K
Net Calls
-$82K
Net Calls Change
-$46K

Top Buyers

1
BCM
BML Capital Management
Indiana
+$2.36M
2
AC
Almitas Capital
California
+$2.35M
3
Morgan Stanley
Morgan Stanley
New York
+$1.66M
4
Goldman Sachs
Goldman Sachs
New York
+$1.33M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.26M

Top Sellers

1
RI
RTW Investments
New York
-$5.93M
2
SCM
Soleus Capital Management
Connecticut
-$2.42M
3
PM
Prosight Management
Texas
-$2.12M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.99M
5
Principal Financial Group
Principal Financial Group
Iowa
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
SOCM
1
SR One Capital Management
Pennsylvania
$17.3M – – –
LGM
2
Logos Global Management
California
$13.3M – – –
BlackRock
3
BlackRock
New York
$6.31M -$54.2K -23,673 -1%
Citadel Advisors
4
Citadel Advisors
Florida
$4.86M -$1.99M -868,299 -32%
BBA
5
Baker Bros. Advisors
New York
$3.98M – – –
TCM
6
Tang Capital Management
California
$3.92M +$299K +130,675 +10%
Morgan Stanley
7
Morgan Stanley
New York
$2.88M +$1.66M +726,704 +202%
BCM
8
BML Capital Management
Indiana
$2.73M +$2.36M +1,029,478 New
AC
9
Almitas Capital
California
$2.72M +$2.35M +1,026,068 New
Goldman Sachs
10
Goldman Sachs
New York
$2.71M +$1.33M +579,225 +130%
Vanguard Group
11
Vanguard Group
Pennsylvania
$2.64M +$23.9K +10,448 +1%
State Street
12
State Street
Massachusetts
$1.84M +$5.73K +2,501 +0.4%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.76M +$64.2K +28,024 +4%
Renaissance Technologies
14
Renaissance Technologies
New York
$1.72M +$1.11M +484,600 +295%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$1.55M +$1.08M +472,200 +419%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$1.46M +$1.26M +549,118 New
Two Sigma Investments
17
Two Sigma Investments
New York
$1.13M +$835K +364,336 +571%
Millennium Management
18
Millennium Management
New York
$1.11M -$938K -409,417 -49%
Northern Trust
19
Northern Trust
Illinois
$988K +$114K +49,668 +15%
Walleye Capital
20
Walleye Capital
New York
$960K -$25.5K -11,126 -3%
PGCM
21
Prescott Group Capital Management
Oklahoma
$909K +$373K +163,000 +91%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$770K +$639K +278,888 +2,376%
PM
23
Prosight Management
Texas
$742K -$2.12M -923,745 -77%
Assenagon Asset Management
24
Assenagon Asset Management
Luxembourg
$650K -$6.46K -2,820 -1%
CS
25
Candriam SCA
Luxembourg
$596K – – –
1
2 3 4 5

DSGN Hedge Fund Activity: Q4 2023 in Review

88 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Design Therapeutics (DSGN) for Q4 2023, worth a combined $85.5M — up 10% from $77.6M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DSGN positions and 14 closed out — a net gain of 1 holder — while 36 added to existing stakes and 25 trimmed.

The largest buyer was BML Capital Management, opening a new position worth an estimated $2.36M. The largest seller was RTW Investments, exiting entirely with an estimated $5.93M sold.

  • 88 institutional investors held Design Therapeutics (DSGN) as of Q4 2023, up from 87 in Q3 2023.
  • Funds reported $85.5M of Design Therapeutics stock for Q4 2023, up 10% quarter-over-quarter.
  • 15 funds opened new Design Therapeutics positions in Q4 2023 and 14 closed out, a net change of +1 holder.
  • The largest Design Therapeutics buyer in Q4 2023 was BML Capital Management, an estimated $2.36M added.
  • The largest Design Therapeutics seller in Q4 2023 was RTW Investments, an estimated $5.93M sold.

Based on aggregated 13F filings for Q4 2023.